RGT 1.79% 28.5¢ argent biopharma limited

Ann: Phase II Clinical Trial on COVID-19 Patients Commenced, page-20

  1. 683 Posts.
    lightbulb Created with Sketch. 270
    Article just released on MGC Pharma's ArtemiC:

    https://thegreenfund.com/is-mgc-pharma-sitting-on-a-covid-19-cure

    About a 5min read.

    'Results from MGC Pharma's double-blind Phase II trial on COVID-19 patients in Israel are due in early August, so they could come any day now. When the results arrive, investors should be keeping a keen eye on whether ArtemiC can successfully minimize the body's immunological response to COVID-19, and to what extent'.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.005(1.79%)
Mkt cap ! $13.79M
Open High Low Value Volume
28.5¢ 28.5¢ 28.5¢ $99 347

Buyers (Bids)

No. Vol. Price($)
2 14314 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 1000 1
View Market Depth
Last trade - 11.04am 26/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.